Variant report
Variant | nsv971548 |
---|---|
Chromosome Location | chr7:11212186-11217961 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr7:11215693-11215816 | K562 | blood: | n/a | n/a |
2 | CCNT2 | chr7:11217186-11217420 | K562 | blood: | n/a | n/a |
3 | E2F4 | chr7:11216210-11216391 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | EBF1 | chr7:11215348-11215367 | GM12878 | blood: | n/a | n/a |
5 | EP300 | chr7:11216268-11217680 | SK-N-SH | brain: | n/a | n/a |
6 | GATA2 | chr7:11216784-11217155 | SH-SY5Y | brain: | n/a | n/a |
7 | GATA3 | chr7:11216478-11217174 | SK-N-SH | brain: | n/a | n/a |
8 | GATA3 | chr7:11216585-11217121 | SH-SY5Y | brain: | n/a | n/a |
9 | MAFK | chr7:11216852-11217028 | HepG2 | liver: | n/a | chr7:11216881-11216898 |
10 | POLR2A | chr7:11216811-11217209 | SK-N-MC | brain: | n/a | n/a |
11 | POLR2A | chr7:11215648-11215970 | H1-neurons | neurons: | n/a | n/a |
12 | POLR2A | chr7:11212740-11213357 | GM12878 | blood: | n/a | n/a |
13 | TCF7L2 | chr7:11215360-11216000 | HEK293 | kidney: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:11205391..11208108-chr7:11211440..11214054,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000230333 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs137964813 | chr7:11212307-11212308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs538567526 | chr7:11212324-11212325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs368391703 | chr7:11212494-11212495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183322060 | chr7:11212507-11212508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs142959717 | chr7:11212625-11212626 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs565486994 | chr7:11212639-11212640 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs143509260 | chr7:11212645-11212646 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs147148154 | chr7:11212650-11212651 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs370754085 | chr7:11212692-11212693 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554410721 | chr7:11212710-11212711 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs561163605 | chr7:11212711-11212712 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs140296242 | chr7:11212812-11212813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs574698680 | chr7:11212819-11212820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548834976 | chr7:11212827-11212828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559387332 | chr7:11212832-11212833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs528118743 | chr7:11212848-11212849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556993746 | chr7:11212888-11212889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2353790 | chr7:11212899-11212900 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs571212177 | chr7:11212907-11212908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs537350563 | chr7:11212947-11212948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185839718 | chr7:11212998-11212999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs73286548 | chr7:11213004-11213005 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs536425098 | chr7:11213015-11213016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs189759446 | chr7:11213019-11213020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs552798741 | chr7:11213050-11213051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs573285120 | chr7:11213052-11213053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs538711993 | chr7:11213060-11213061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs558921106 | chr7:11213079-11213080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs182452993 | chr7:11213189-11213190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs145077351 | chr7:11213215-11213216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs560568575 | chr7:11213217-11213218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs532489270 | chr7:11213220-11213221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs377447967 | chr7:11213244-11213245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs561227452 | chr7:11213311-11213312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574729148 | chr7:11213418-11213419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs55804401 | chr7:11213421-11213422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs34411096 | chr7:11213448-11213449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs117021510 | chr7:11213485-11213486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs115354637 | chr7:11213491-11213492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs528190050 | chr7:11213492-11213493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs551147154 | chr7:11213514-11213515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564887555 | chr7:11213525-11213526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs530488189 | chr7:11213530-11213531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550921304 | chr7:11213539-11213540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs371916898 | chr7:11213548-11213549 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs75734743 | chr7:11213607-11213608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs546777078 | chr7:11213694-11213695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs541675493 | chr7:11213706-11213707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs112157739 | chr7:11213721-11213722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs373674535 | chr7:11213730-11213731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Medulloblastoma | 17653508 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Autism | 22495309 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:11107600-11212200 | Weak transcription | Fetal Kidney | kidney |
2 | chr7:11170600-11217400 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
3 | chr7:11175400-11213200 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
4 | chr7:11189200-11214000 | Weak transcription | Primary hematopoietic stem cells | blood |
5 | chr7:11190000-11213200 | Weak transcription | Dnd41 | blood |
6 | chr7:11204200-11213200 | Weak transcription | Primary B cells from cord blood | blood |
7 | chr7:11204400-11217400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
8 | chr7:11207000-11226000 | Weak transcription | Gastric | stomach |
9 | chr7:11211000-11212200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr7:11211600-11215400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr7:11212600-11212800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
12 | chr7:11215000-11215800 | Enhancers | Fetal Intestine Small | intestine |
13 | chr7:11215400-11216000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr7:11217200-11217800 | Enhancers | Osteobl | bone |
15 | chr7:11217200-11218000 | Enhancers | Muscle Satellite Cultured Cells | -- |
16 | chr7:11217400-11217600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
17 | chr7:11217400-11218000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
18 | chr7:11217600-11218000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |